Antiplatelet medications in the secondary prevention of ischemic stroke

被引：0
作者：
James D. Fleck
机构：
[1] Indiana University School of Medicine,Department of Neurology
来源：
Current Neurology and Neuroscience Reports | 2005年 / 5卷 / 1期
关键词：
Aspirin; Clopidogrel; Dipyridamole; Ticlopidine; Telmisartan;
D O I：
10.1007/s11910-005-0015-2
中图分类号：
学科分类号：
摘要：
It is difficult to make general statements regarding choices in the medical management of patients with IS given its multiple mechanisms and individual patient variations. It is exceedingly important to manage all vascular risk factors in each patient, especially hypertension. Managing risk factors is as important as, or perhaps more important than, deciding on a prevention medication. Based on the previous discussion, I present my recommendations for antiplatelet secondary prevention of noncardioembolic IS.
引用
收藏
页码：1 / 3
页数：2
相关论文
共 50 条
[21]   Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review [J].
Valis, Martin ;
Klimova, Blanka ;
Novotny, Michal ;
Herzig, Roman .
FRONTIERS IN NEUROLOGY, 2021, 12
[22]   Selecting an Optimal Antiplatelet Agent for Secondary Stroke Prevention [J].
Albright, Karen C. ;
Howard, Virginia J. ;
Howard, George .
NEUROLOGY-CLINICAL PRACTICE, 2021, 11 (02) :E121-E128
[23]   Aspirin and Antiplatelet Agent ResistanceImplications for Prevention of Secondary Stroke [J].
David M. Greer .
CNS Drugs, 2010, 24 :1027-1040
[24]   Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis [J].
Wang, Wen ;
Zhang, Lu ;
Liu, Weiming ;
Zhu, Qin ;
Lan, Qing ;
Zhao, Jizong .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (05) :1081-1089
[25]   Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study [J].
Gallo, Andrea ;
Galliazzo, Silvia ;
Grazioli, Stefano ;
Guasti, Luigina ;
Ageno, Walter ;
Squizzato, Alessandro .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) :336-344
[26]   Dual Antiplatelet Therapy of Clopidogrel and Aspirin in Secondary Prevention of Ischemic Stroke: Evidence and Indications [J].
Su, Ya ;
Cheng, Xin ;
Dong, Qiang .
CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (11) :870-876
[27]   Antiplatelet Strategies for Secondary Prevention of Stroke and TIA [J].
Ishida, Koto ;
Messe, Steven R. .
CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (11)
[28]   Antiplatelet Therapy for Secondary Prevention in Stroke - Making the Right Choice [J].
Ling, Geoffrey .
CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (02) :225-237
[29]   Trends in the Use of Medications for Secondary Ischemic Stroke Prevention in Denmark, 2005-2021 [J].
Skajaa, Nils ;
Laugesen, Kristina ;
Lauffenburger, Julie C. ;
Schwamm, Lee H. ;
Sorensen, Henrik T. ;
Patorno, Elisabetta .
NEUROLOGY, 2024, 102 (09)
[30]   Dual Antiplatelet Therapy for the Acute Management and Long-term Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack, An Updated Review [J].
Chan, Bernard P. L. ;
Wong, Lily Y. H. ;
Tan, Benjamin Y. Q. ;
Yeo, Leonard L. L. ;
Venketasubramanian, Narayanaswamy .
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (02)
12345